Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 02 November 2026 Vol. No. 15 ; Issue No.759
Publications

1. Joshi R, Nath S, Gupta S (2026). Telomere Dynamics in Congenital Heart Defects: Hidden Architects of Cardiogenesis? Human Mutation

2. Maddirala H, Siva M, Kumari S (2026). Primary malignant vaginal melanoma-navigating rarity, aggressiveness and therapeutic uncertainty. BMJ Case Reports. 19(10):e274596

3. Gillessen S, Turco F, Davis ID, Efstathiou JA, Emmett L... Murthy V, Mutambirwa SBA, Nguyen PL, O'Sullivan JM...etal (2026) Management of Patients with High-risk Localised, Locally Advanced, and Biochemically Recurrent Prostate Cancer: Report from the 2026 Advanced Prostate Cancer Consensus Conference. European Urology.

4. Khurud P, Munshi A, Wadasadawala T (2026). Commentary on: Postmastectomy chest-wall irradiation effects on 10-year survival in early breast cancer. Journal of Cancer Research and Therapeutics. 22(5):996-998.

5. Sekar A, Rekhi B, Ghosh J, Menon S, Shetty O, Deodhar K, Rath S, Mittal N, Mehta A, Gulia S, Maheshwari A, Chopra S, Gupta S (2026). A retrospective analysis of BCOR-immunohistochemistry positive uterine sarcomas: Clinical features and survival. Journal of Cancer Research and Therapeutics. 22(5):884-891.

6. Kazi M, Reddy KS, Sharma A, De Souza A, Saklani A (2026). Patterns and predictors of relapse following cytoreductive surgery for Pseudomyxoma Peritonei. Journal of Surgical Oncology.

7. Hande V, Ndarukwa S, Rubio AP, Berger D, Anacak Y, Sucharski M, Flores JAS, Agarwal JP, Msadabwe SC, Gamboa E, Mwaiselage JD, Vanchinbazar E, Sanaa EM, Batyrkanova C, Shami A, Alanyali S, Sabaddin NA, Sukhin V, Jaksic B, Tamaki T, Chopra S (2026). Implementing Image-Guided Brachytherapy (IGBT) For Cervical Cancer in Resource-Limited Settings: An International Multicentric Cross-Sectional Study of Resource and Workflow Impact. International Journal of Radiation Oncology, Biology, Physics.

8. Prakash G, Gota V, Sharma D, Chopra S, Pal M, Arora A, Nagarajan R, Misra A, Bakshi G, Murthy V, Maitre P, Gurram L, Mittal P, Patwardhan R, Checker R, Joshi M, Madki S, Gupta S, Kumar S, Bonkar Dethe S, Gawad P, Ghadge S, Menon S, Ghanty T, Kannan S, Badwe R, Chaturvedi P, Gupta S, Sandur S (2026). Phase II Non-Randomised Trial of Oral Chlorophyllin in Haemorrhagic Cystitis from Radiation Therapy (CLARITY Trial): clinical and quality-of-life outcomes with exploratory proteomics. Scientific Reports.

Book Chapter

1. Shettigar A, Fernandes L, Bal M, Prabhash K, Chandrani P. (2026). Oncogene-Driven Thyroid Cancer and Its Therapeutic Implications. In:Kostoglou-Athanassiou I(Ed.), Thyroid Cancer - Novel Aspects in Pathogenesis and Treatment Oncology. IntechOpen. ISBN: (978-1-80631-181-1)

Proceedings Publication

1. Poladia P, Tupe R, Chavan P, Naresh C, Pagdhune A (2026). From data to quality: Using Six Sigma to assess lab performance. In: Proceedings of the Conference on Bioengineering for Global Health (SYMRESEARCH 2.0 2025). Advances in Biological Sciences Research. Vol.55

Site of the Week

MetaGraph indexes and compresses vast collections of DNA, RNA, and protein sequences

desktop Image
Interesting Reads

Pérol M, Yoshida T, Ahn MJ, Gay CM, Schuler M, Liu H, Sezer A, Bilici A, Korantzis I, Lim SM, Otsubo K, Juan-Vidal O, Chen Y, Schvartsman G, Wang H, Dingemans AC, Clarke JM, Desai A, Marigil M, Chen Y, Abidi B, Wang J, Sands J; DeLLphi-305 Investigators (2026). Tarlatamab-Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer. New England Journal of Medicine.

Video of the Week
Health Policy and Cancer
Upcoming Events
Conference on Hodgkin lymphoma in ACTREC

November 20-21, 2026

At ACTREC, Tata Memorial Centre, Kharghar

EMBO Global Lecture Series

November 23, 2026

At ACTREC, Tata Memorial Centre, Kharghar

ICGCW 2026 8th Indian Cancer Genetics Conference & Workshop

November 25-29, 2026

At ACTREC, Tata Memorial Centre, Kharghar

Do You Know?

In 2001, Results of a clinical trial showed that the drug imatinib mesylate, which targets a unique protein produced by the Philadelphia chromosome, is effective against chronic myelogenous leukemia (CML).

back Image
Cancer News
Immune changes linked to diabetes could guide development of new cancer treatments.

MedicalXpress, 29/10/2026

The researchers found that T cells from hyperglycemic mice had an increase in their use of a particular cellular signaling pathway, which contributed to the T cells' increased cancer-fighting ability …

Activating cancer-fighting protein could make T-cell immunotherapies more effective, study finds.

EurekAlert, 29/10/2026

The findings suggest that adding a drug during the preparation of engineered immune cells could offer a relatively simple way to improve existing T-cell therapies without requiring additional genetic modifications...

A metabolic–epigenetic pathway drives immune suppression in colorectal cancer

Nature Cancer, 28/10/2026

Tumor-associated neutrophils are being recognized as regulators of cancer immune evasion but the pathways that drive their pathogenic states remain unclear. A study now reveals a metabolic–chromatin crosstalk via a GSK3β–FH–fumarate–KDM2B axis that epigenetically reprograms neutrophils...

2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)